CRISPR Therapeutics AG (CRSP)
53.46
-1.18
(-2.16%)
USD |
NASDAQ |
Feb 20, 16:00
53.79
+0.33
(+0.62%)
Pre-Market: 20:00
CRISPR Therapeutics SG&A Expense (Quarterly) : 18.40M for Dec. 31, 2025
SG&A Expense (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
SG&A Expense (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
SG&A Expense (Quarterly) Benchmarks
| Vertex Pharmaceuticals, Inc. | 487.00M |
| Beam Therapeutics, Inc. | 26.74M |
| Novartis AG | 3.440B |
| Recursion Pharmaceuticals, Inc. | 41.63M |
| EvoNext Holdings SA | -- |